Targeting the unfolded protein response in head and neck and oral cavity cancers
- PMID: 31075256
- PMCID: PMC6867800
- DOI: 10.1016/j.yexcr.2019.04.007
Targeting the unfolded protein response in head and neck and oral cavity cancers
Abstract
Many FDA-approved anti-cancer therapies, targeted toward a wide array of molecular targets and signaling networks, have been demonstrated to activate the unfolded protein response (UPR). Despite a critical role for UPR signaling in the apoptotic execution of cancer cells by many of these compounds, the authors are currently unaware of any instance whereby a cancer drug was developed with the UPR as the intended target. With the essential role of the UPR as a driving force in the genesis and maintenance of the malignant phenotype, a great number of pre-clinical studies have surged into the medical literature describing the ability of dozens of compounds to induce UPR signaling in a myriad of cancer models. The focus of the current work is to review the literature and explore the role of the UPR as a mediator of chemotherapy-induced cell death in squamous cell carcinomas of the head and neck (HNSCC) and oral cavity (OCSCC), with an emphasis on preclinical studies.
Keywords: ER stress; HNSCC; Head and neck squamous cell carcinoma; Natural products; Oral cavity squamous cell carcinoma; Unfolded protein response.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
None.
Figures
References
-
- Siegel R, et al., Cancer statistics, 2014, Ca- Cancer J. Clin 64 (1) (2014) 9–29. - PubMed
-
- Siegel R, Naishadham D, Jemal A, Cancer statistics, 2013, Ca- Cancer J. Clin 63(1) (2013) 11–30. - PubMed
-
- Fribley AM, et al., Recent trends in oral cavity cancer research support in the United States, J. Dent. Res 96 (1) (2017) 17–22. - PubMed
-
- Blasco MA, et al., Recent Trends in Oropharyngeal Cancer Funding and Public Interest, Laryngoscope, 2017. - PubMed
-
- Svider PF, et al., Head and neck cancer, Otolaryngol. Head Neck Surg. 156 (1) (2017) 10–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
